Stay updated with breaking news from Nasdaq Nrix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.45) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.57) by $0.12, MarketWatch Earnings reports. Nurix Therapeutics had a negative net margin of 428.29% and a negative return on equity of 60.17%. Nurix Therapeutics Stock […]
Nurix Therapeutics (NASDAQ:NRIX – Free Report) will be releasing its earnings data on Wednesday, July 5th. Nurix Therapeutics (NASDAQ:NRIX – Free Report) last announced its earnings results on Thursday, April 13th. The company reported ($0.75) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.15. Nurix Therapeutics had a negative return on equity […]
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Rating) shares dropped 5.5% during mid-day trading on Thursday . The stock traded as low as $10.97 and last traded at $10.97. Approximately 65,051 shares traded hands during trading, a decline of 81% from the average daily volume of 337,233 shares. The stock had previously closed at $11.61. Wall […]
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Rating) has been given an average rating of “Moderate Buy” by the twelve research firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month target […]
Denali Advisors LLC raised its holdings in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Rating) by 63.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,900 shares of the company’s stock after purchasing an additional 2,300 shares during the […]